Shared Research Project

项目总结(见说明)： 共享研究项目的目的是开发一种创新和有效的基于移动电话的应用程序，以帮助非专科卫生工作者检测和管理抑郁症(非专科卫生工作者的移动健康-莫霍克)，最终目标是缩小治疗差距 通过提高mhGAP指南交付的保真度来治疗抑郁症。共享研究部分的具体目标是： 1.与我们的技术合作伙伴合作开展莫霍克的技术开发。 2.评估莫霍克方案的可接受性和可行性，并提供初步证据，说明其在每个中心的环境中的影响。 3.根据这些经验教训改进和最后确定莫霍克应用程序，为今后在区域技术合作和扩大规模中进行正式评估做准备。 莫霍克建立在可扩展的、经济高效的移动医疗技术之上，该技术可用于任何资源匮乏的地区，在LMIC的覆盖范围迅速扩大，在医疗保健应用中的适用性和接受度不断提高，并可扩展到其他几种MNS疾病。它的设计目的是供从初级保健医生到社区卫生工作者的任何非专科卫生工作者干部使用。它有可能通过任务转移来改善抑郁症患者的筛查和诊断，启动基于mhGAP的循证治疗，并对抑郁症患者进行随访，从而为缩小治疗差距和改善抑郁症患者的预后做出重大贡献。 最佳的临床结果。莫霍克将通过在三个地点(每个中心一个)分两个阶段的三年合作工作方案实现其目标：(1)发展莫霍克的核心能力和形成性研究，以确保在三个中心的每个地点有效实施莫霍克；以及(2)在这三个地点的试探性试验中对莫霍克进行评估，包括进程 评估和形成性研究，为扩大莫霍克的规模提供信息。

PROJECT SUMMARY (See instructions): The aim of the shared research project is to develop an innovative and effective mobile phone based application to aid non-specialist health workers in the detection and management of depression (Mobile Health for non-specialists health WorKers - MOHAWK) with the ultimate goal of reducing the treatment gap for depression by improving the fidelity with which mhGAP guidelines are delivered. The specific objectives of the shared research component are: 1. To carry out the technical development of MOHAWK in collaboration with our technology partners. 2. To evaluate the acceptability and feasibility of MOHAWK and to provide preliminary evidence of its impact in settings in each of the Hubs. 3. To refine and finalise the MOHAWK application based on these lessons in preparation for future formal evaluation in an RCT and scaling up. MOHAWK is built on scalable, cost-effective mobile health technology which can be used in any resource poor area, has a rapidly increasing coverage in LMIC, has growing applicability and acceptability in health care applications, and can be extended to several other MNS disorders. It is designed to be used by any cadre of non-specialist health worker from primary care physicians and CHWs to lay health workers. It has the potential to make a major contribution to reducing the treatment gap and improving outcomes for people suffering from depression by enabling task-shifting to improve the screening and diagnosis, initiation of evidence based treatments derived from mhGAP, and follow-up of patients with depression to achieve optimal clinical outcomes. MOHAWK will achieve its objectives through a three year collaborative programme of work in three sites (one from each Hub) in two phases: (1) the development of MOHAWK core capabilities and formative research to ensure effective implementation of MOHAWK to each of the three Hub sites; and (2) the evaluation of MOHAWK in exploratory trials in these three sites including process evaluation and formative research to inform the scale up of MOHAWK.